| Literature DB >> 34179639 |
Chanwoo Park1,2, Jeong Min Hwang1, Yongmin Go1, Heenang Choi1, Bo Keun Park1, Chang Gyoun Kim1, Ji Yeon Ryu1, Chang Seop Hong2, Taek-Mo Chung1.
Abstract
New heteroleptic strontium complexes were synthesized using substitution reaction of bis(trimethylsilyl)amide of Sr(btsa)2·2DME with aminoalkoxide and β-diketonate ligands. The complexes [Sr(bdmp)(btsa)]2·2THF (1), [Sr(bdeamp)(btsa)]2 (2), [Sr(dadamb)(btsa)]2 (3), [Sr(bdmp)(hfac)]3 (4), [Sr(bdeamp)(hfac)]3 (5), [Sr(dadamb)(hfac)]3 (6), and [Sr3(dadamb)4(tmhd)2] (7) were prepared and characterized by means of various analysis techniques such as Fourier transform infrared, NMR, thermogravimetric analysis, and elemental analysis. Complexes 1-3 were further structurally confirmed by single-crystal X-ray crystallography, and they displayed dimeric structures in which strontium atoms were connected by alkoxide oxygen atoms of the μ2 type. Compound 1 has a trigonal prismatic structure, whereas 2 and 3 have a distorted square pyramidal structure. In complexes 5-7, trimeric structures were obtained with strontium atoms connected by μ3-O bonds of alkoxide oxygen atoms and μ2-O bonds of alkoxide and β-diketonate oxygen atoms. The crystal structures of 5, 6, and 7 showed distorted capped octahedral geometry, while 7 (middle Sr atom) displayed a distorted trigonal prism geometry. Complexes 5-7 displayed ∼70% mass loss in the temperature range from 25 to 315 °C.Entities:
Year: 2021 PMID: 34179639 PMCID: PMC8223417 DOI: 10.1021/acsomega.1c01624
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Scheme 1
Scheme 2
Scheme 3
Scheme 4
Scheme 5Crystallographic Data and Data Collection Parameters for 1–7
| compound | ||||||
|---|---|---|---|---|---|---|
| formula weight | 930.68 | 814.56 | 842.58 | 1316.79 | 1403.87 | 1322.5 |
| temperature (K) | 100(1) | 100(1) | 100(1) | 100(1) | 100(1) | 100(1) |
| wavelength (Å) | 0.71073 | 0.71073 | 0.71073 | 0.71073 | 0.71073 | 0.71073 |
| crystal system | triclinic | triclinic | orthorhombic | monoclinic | triclinic | monoclinic |
| space group | ||||||
| 10.027(2) | 9.0705(5) | 12.2155(9) | 17.8520(7) | 12.058(3) | 18.0400(14) | |
| 10.505(2) | 10.4979(6) | 18.9312(14) | 14.2227(5) | 12.438(3) | 11.5817(9) | |
| 12.868(3) | 12.2680(7) | 20.4702(16) | 23.1741(9) | 21.422(6) | 35.591(3) | |
| α (deg) | 86.037(12) | 94.399(3) | 90 | 90 | 93.087(16) | 90 |
| β (deg) | 72.800(10) | 106.772(3) | 90 | 97.147(2) | 101.598(14) | 103.789(4) |
| γ (deg) | 81.722(11) | 96.640(3) | 90 | 90 | 110.133(13) | 90 |
| V (Å3) | 1280.8(5) | 1103.51(11) | 4733.8(6) | 5750.5(4) | 2928.4(12) | 7221.9(10) |
| 2 | 2 | 8 | 4 | 2 | 8 | |
| ρcalcd. (mg/m3) | 1.207 | 1.226 | 1.182 | 1.573 | 1.592 | 1.216 |
| μ (mm–1) | 2.212 | 2.555 | 2.384 | 2.882 | 2.832 | 2.258 |
| F(000) | 496 | 432 | 1792 | 2736 | 1416 | 2816 |
| crystal size (mm3) | 0.24 × 0.10 × 0.10 | 0.16 × 0.14 × 0.12 | 0.30 × 0.30 × 0.20 | 0.30 × 0.14 × 0.08 | 0.20 × 0.10 × 0.02 | 0.12 × 0.08 × 0.06 |
| theta range (deg) | 1.66 to 26.73 | 2.47 to 29.57 | 1.99 to 28.34 | 1.68 to 27.88 | 1.76 to 26.02 | 2.11 to 27.88 |
| index ranges | –11 ≤ | –12 ≤ | 0 ≤ | –23 ≤ | –14 ≤ | –22 ≤ |
| –13 ≤ | –14 ≤ | 0 ≤ | 0 ≤ | –15 ≤ | –15 ≤ | |
| –16 ≤ | –17 ≤ | 0 ≤ | 0 ≤ | 0 ≤ | –21 ≤ | |
| indep. refl. (Rint) | 5366 (0.0000) | 6067 (0.0408) | 5873 (0.0000) | 13,714 (0.0000) | 11,446 (0.0000) | 8578 (0.0761) |
| parameters | 246 | 201 | 200 | 701 | 733 | 346 |
| GOF on | 1.105 | 0.966 | 1.045 | 1.035 | 1.013 | 1.026 |
| 0.0553 | 0.0553 | 0.0346 | 0.0566 | 0.0628 | 0.0527 | |
| 0.1473 | 0.1362 | 0.0783 | 0.1454 | 0.175 | 0.1219 |
Figure 1Crystal structure of [Sr(bdmap)(btsa)]2·2THF (1). Hydrogens attached to carbon and atoms in the minor component of the disordered bdmap have been omitted for clarity.
Figure 3Crystal structure of [Sr(dadamb)(btsa)]2 (3).
Figure 4Crystal structure of [Sr(bdeamp)(hfac)]3 (5). Hydrogens attached to carbon and atoms in the minor component of the disordered bdeamp have been omitted for clarity.
Figure 5Crystal structure of [Sr(dadamb)(hfac)]3 (6). Fluorine atoms in the minor component of the disordered hfac ligand have been omitted for clarity.
Figure 6Crystal structure of [Sr3(damdamb)4(tmhd)2] (7).
Figure 7TGA plots of complexes 4 (black), 5 (red), 6 (blue), and 7 (green).